ISLAMABAD; Novo Nordisk Pakistan hosted “Unordinary Partnerships to Shape a Healthier Tomorrow” that brought together healthcare professionals, policymakers, and leaders to address the crucial issue of serious chronic diseases, particularly obesity, which impacts millions across Pakistan.
The event was graced by the Ambassador of Denmark to Pakistan, H.E. Jakob Linulf, along with the senior management of Novo Nordisk Pakistan. Speaking at the occasion, H.E. Jakob Linulf, the Danish Ambassador to Pakistan, emphasized on the importance of collaboration, in healthcare by Danish companies like Novo Nordisk operating in Pakistan.
He said, “Partnerships are essential in the fight against obesity. Together, we can foster a healthier society and defeat obesity. I am confident that this culture will continue to positively impact the people of Pakistan”. Rashed Rafique Butt, General Manager of Novo Nordisk Pakistan, shared the organization’s 100-year legacy of embracing new ideas and different approaches to defeat serious chronic disease which is reflected in their new corporate brand platform – Unordinary Drives Change.
He stated, “Having pioneered scientific breakthroughs, and with over 25 years of obesity research, our GLP-1 treatment supports millions in achieving effective weight loss. Addressing obesity requires collaboration and concerted efforts with diverse network of organizations and stakeholders including government, associations, communities and NGOs—to overcome barriers and drive real change for a healthier future for all”.
Highlighting the urgent need for action, Dr. Javed Akram, President, Pakistan Society of Internal Medicine, emphasized that obesity affects nearly 38 million people in Pakistan and is classified as a disease by the World Health Organization. He acknowledged the extensive impact of obesity on both individuals and the healthcare system.
Meanwhile, Dr. A H Amir, President, Pakistan Society of Obesity, urged the stakeholders to prioritize countering obesity in the public health discussions, advocating for an inclusive approach that promotes prevention and management while combating the stigma around obesity through effective media campaigns. The event concluded with a unified call to action, encouraging attendees to raise awareness and build collaborative efforts to combat the obesity epidemic in Pakistan.
Novo Nordisk Pakistan remains committed to dedicated to leading the way in defeating obesity where healthier, longer lives are not just a possibility for some, but a reality for many.
About Novo Nordisk Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes.
